Clinical Trials Logo
  1. Home
  2. Partial Seizures
  3. NCT00327717

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Partial Seizures Clinical Trial

Official title:
A Multicenter, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Clinical Trial Summary

The objectives of this trial are to evaluate the safety and efficacy of Zonisamide as adjunctive therapy in medically refractory patients receiving other antiepileptic drugs (AEDs).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00327717
Study type Interventional
Source Eisai Inc.
Contact
Status Completed
Phase Phase 3
Start date September 2006
Completion date May 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01954121 - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Phase 3
Completed NCT01630057 - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Phase 4
Completed NCT00537238 - Pregabalin Versus Levetiracetam In Partial Seizures Phase 3
Completed NCT00141258 - Pregabalin Epilepsy Add-On Trial Phase 3
Completed NCT03340064 - A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age Phase 3
Terminated NCT00407797 - Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial Phase 4
Completed NCT01136954 - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) Phase 3
Completed NCT04257604 - A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
Completed NCT01392768 - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Phase 3
Completed NCT01063764 - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Phase 3
Completed NCT00102713 - A Study for Treatment of Partial Seizures in Children Phase 3
Completed NCT01262677 - Once-A-Day Pregabalin For Partial Seizures Phase 3